The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development.
Animals
Antibodies, Neutralizing
/ pharmacology
Antibodies, Viral
/ immunology
Biomarkers
Ebolavirus
/ drug effects
Genes, Viral
Glycoproteins
/ genetics
Hemorrhagic Fever, Ebola
/ immunology
Humans
Immune Evasion
Immunity, Innate
Protein Modification, Translational
Viral Envelope Proteins
/ genetics
Virulence Factors
/ genetics
Virus Replication
Ebola virus
GP
filovirus
glycoprotein
pathogenesis
sGP
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
31 10 2019
31 10 2019
Historique:
received:
07
10
2019
revised:
28
10
2019
accepted:
29
10
2019
entrez:
6
11
2019
pubmed:
7
11
2019
medline:
3
7
2020
Statut:
epublish
Résumé
Ebola virus (EBOV) is a highly lethal pathogen that has caused several outbreaks of severe hemorrhagic fever in humans since its emergence in 1976. The EBOV glycoprotein (GP
Identifiants
pubmed: 31683550
pii: v11110999
doi: 10.3390/v11110999
pmc: PMC6893644
pii:
doi:
Substances chimiques
Antibodies, Neutralizing
0
Antibodies, Viral
0
Biomarkers
0
Glycoproteins
0
Viral Envelope Proteins
0
Virulence Factors
0
envelope glycoprotein, Ebola virus
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Clin Infect Dis. 2015 Nov 15;61(10):1627-8
pubmed: 26197842
Nature. 2014 Oct 2;514(7520):47-53
pubmed: 25171469
J Hosp Infect. 2015 May;90(1):1-9
pubmed: 25655197
J Virol. 2007 Feb;81(4):1821-37
pubmed: 17151111
J Infect Dis. 2015 Oct 1;212 Suppl 2:S226-33
pubmed: 26138826
J Immunol. 2000 Jan 15;164(2):953-8
pubmed: 10623844
Viral Immunol. 2015 Feb;28(1):3-9
pubmed: 25354393
Cell. 2016 Jun 2;165(6):1467-1478
pubmed: 27238017
J Infect Dis. 2011 Nov;204 Suppl 3:S897-903
pubmed: 21987767
J Virol. 2005 Aug;79(16):10442-50
pubmed: 16051836
J Infect Dis. 1999 Feb;179 Suppl 1:S1-7
pubmed: 9988155
J Infect Dis. 2015 Oct 1;212 Suppl 2:S129-37
pubmed: 25810440
PLoS Pathog. 2014 Nov 20;10(11):e1004509
pubmed: 25412102
Cell Immunol. 2018 Feb;324:24-32
pubmed: 29195741
Viruses. 2015 Sep 29;7(10):5172-90
pubmed: 26426036
J Gen Virol. 2001 Dec;82(Pt 12):2839-2848
pubmed: 11714958
N Engl J Med. 2014 Nov 27;371(22):2054-7
pubmed: 25372854
Virology. 1998 Oct 25;250(2):408-14
pubmed: 9792851
Proc Natl Acad Sci U S A. 1998 May 12;95(10):5762-7
pubmed: 9576958
J Virol. 2010 Jan;84(1):27-33
pubmed: 19846529
Science. 2001 Mar 9;291(5510):1965-9
pubmed: 11239157
PLoS Pathog. 2013;9(5):e1003258
pubmed: 23696729
Proc Natl Acad Sci U S A. 2018 Aug 7;115(32):E7578-E7586
pubmed: 30038008
J Gen Virol. 2019 Jun;100(6):911-912
pubmed: 31021739
J Virol Methods. 2007 Jul;143(1):29-37
pubmed: 17368819
J Infect Dis. 2011 Nov;204 Suppl 3:S941-6
pubmed: 21987773
J Infect Dis. 2015 Oct 1;212 Suppl 2:S242-6
pubmed: 25957965
Annu Rev Pathol. 2017 Jan 24;12:387-418
pubmed: 27959626
EMBO J. 2004 May 19;23(10):2175-84
pubmed: 15103332
J Virol. 2011 Sep;85(17):8502-13
pubmed: 21697477
Virology. 1995 Dec 20;214(2):421-30
pubmed: 8553543
J Infect Dis. 2018 Nov 22;218(suppl_5):S545-S552
pubmed: 29893888
Nat Rev Microbiol. 2019 Oct;17(10):593-606
pubmed: 31341272
Emerg Infect Dis. 2019 May;25(5):
pubmed: 31002301
Viruses. 2015 Jan 20;7(1):285-305
pubmed: 25609303
Cell Rep. 2018 Jan 30;22(5):1159-1168
pubmed: 29386105
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3602-7
pubmed: 8622982
BMJ. 2019 Sep 6;366:l5371
pubmed: 31492688
J Virol. 2011 Jun;85(11):5406-14
pubmed: 21411529
Cell. 2018 Aug 9;174(4):938-952.e13
pubmed: 30096313
J Virol. 2016 Mar 28;90(8):3890-3901
pubmed: 26819310
Curr Top Microbiol Immunol. 2017;411:323-352
pubmed: 28601947
PLoS Pathog. 2012;8(12):e1003065
pubmed: 23271969
J Infect Dis. 2020 Jan 1;221(1):156-161
pubmed: 31301137
J Virol. 2017 Jul 27;91(16):null
pubmed: 28539454
Virology. 1999 Dec 5;265(1):164-71
pubmed: 10603327
Nat Microbiol. 2016 Aug 08;1(9):16128
pubmed: 27562261
Curr Top Microbiol Immunol. 2017;411:381-417
pubmed: 28795188